Abstract
A variety of cytokines have been detected in inflamed intestinal mucosal tissues, including the pro-inflammatory cytokine, interleukin-1 (IL-1), along with growth factors involved in wound healing processes such as proliferation and cell migration. However, little is known about how IL-1 and growth factors interact with intestinal epithelial cells to regulate the production of inflammatory cytokines such as interleukin-8 (IL-8). Previously, we have shown that hepatocyte growth factor (HGF) could significantly enhance IL-1-stimulated IL-8 secretion by the Caco-2 colonic epithelial cell line, yet HGF, by itself, did not stimulate IL-8 secretion. In this report, a second growth factor, keratinocyte growth factor (KGF), was also found to significantly enhance IL-1-induced IL-8 secretion by Caco-2 cells, yet KGF, by itself, also had no effect. Simultaneous addition of both IL-1 and KGF was also required for the enhancing effect. Treatment of the Caco-2 cells with wortmannin or triciribine suppressed the enhancing effect of HGF, suggesting that the effect was mediated by signaling through phosphatidylinositol-3-kinase (PI3K) and the kinase AKT. The enhancing effect of KGF was not affected by wortmannin, but was suppressed by triciribine, suggesting that the effect of KGF was through a PI3K-independent activation of AKT. These results suggest that the growth factors HGF and KGF may play a role in enhancing IL-1-stimulated production of IL-8 by epithelial cells during mucosal inflammations. However, the mechanism by which the growth factors enhance the IL-1 response may be through different initial signaling pathways.
Similar content being viewed by others
References
Arthur L. G.; Schwartz M. Z.; Kuenzler K. A.; Birbe R. Hepatocyte growth factor treatment ameliorates diarrhea and bowel inflammation in a rat model of inflammatory bowel disease. J. Pediatr. Surg. 39: 139–143; 2004.
Bao S.; Wang Y.; Sweeney P.; Chaudhuri A.; Doseff A. I.; Marsh C. B.; Knoell D. L. Keratinocyte growth factor induces Akt kinase activity and inhibits Fas-mediated apoptosis in A549 lung epithelial cells. Lung Cellular Molecular Physiol 288: 36–42; 2005.
Beck P. L.; Podolsky D. K. Growth factors in inflammatory bowel disease. Inflamm. Bowel Dis. 5: 44–60; 1999.
Brauchle M.; Madlener M.; Wagner A. D.; Angermeyer K.; Lauer U.; Hofschneider P. H.; Gregor M.; Werner S. Keratinocyte growth factor is highly overexpressed in inflammatory bowel disease. Am. J. Pathol. 149: 521–529; 1996.
Brazil D. P.; Hemmings B. A. Ten years of protein kinase B signalling: a hard Akt to follow. Trends Biochem. Sci. 26: 657–664; 2001.
Chandrasekher G.; Kakazu A. H.; Bazan H. E. HGF- and KGF-induced activation of PI-3 K/p70 s6 kinase pathway in corneal epithelial cells: its relevance in wound healing. Exp. Eye Res. 73: 191–202; 2001.
Chang Y.; Wang J.; Lu X.; Thewke D. P.; Mason R. J. KGF induces lipogenic genes through a PI3K and JNK/SREBP-1 pathway in H292 cells. J. Lipid Res. 46: 2624–2635; 2005.
Cheng J. Q.; Lindsley C. W.; Cheng G. Z.; Yang H.; Nicosia S. V. The Akt/PKB pathway: molecular target for cancer drug discovery. Oncogene 24: 7482–7492; 2005.
Danese S.; Papa A.; Scaldaferri F.; Graziani C.; Bonizzi M.; Armuzzi A.; Fedeli G.; Gasbarrini G.; Gasbarrini A. A novel pathogenic role for microvasculature in inflammatory bowel disease. Eur. Rev. Med. Pharmacol. Sci. 10: 3–5; 2006.
Dong G.; Chen Z.; Li Z.-Y.; Yen N. T.; Bancroft C. C.; Van Waes C. Hepatocyte growth factor/scatter factor-induced activation of MEK and PI3K signal pathways contributes to expression of proangiogenic cytokines interleukin-8 and vascular endothelial growth factor in head and neck squamous cell carcinoma. Cancer Res. 61: 5911–5918; 2001.
Dinarello C. A. Immunological and inflammatory functions of the interleukin-1 family. Annu. Rev. Immunol. 27: 519–550; 2009.
Eckmann L.; Hung H. C.; Schurer-Maly C.; Panja A.; Morzycka-Wroblewska E.; Kagnoff M. F. Differential cytokine expression by human intestinal epithelial cell lines: regulated expression of interleukin-8. Gastroenterology 105: 1689–1697; 1993.
Finch P. W.; Cheng A. L. Analysis of the cellular basis of keratinocyte growth factor overexpression in inflammatory bowel disease. Gut 45: 848–855; 1999.
Goke M.; Kanai M.; Podolsky D. K. Intestinal fibroblasts regulate intestinal epithelial cell proliferation via hepatocyte growth factor. Am. J. Physiol. 274: G809–G818; 1998.
Greenwood-Van Meerveld B.; Venkova K.; Connolly K. Efficacy of repifermin (keratinocyte growth factor-2) against abnormalities in gastrointestinal mucosal transport in a murine model of colitis. J. Pharm. Pharmacol. 55: 67–75; 2003.
Gross V.; Andus T.; Daig R.; Aschenbrenner E.; Scholmerich J.; Falk W. Regulation of interleukin-8 production in a human colon epithelial cell line (HT 29). Gastroenterology 108: 653–661; 1995.
Grygas J.; Steiger N.; LeSeur C.; Unger B.; McGee D. Hepatocyte growth factor enhances IL-1β stimulated IL-8 secretion by Caco-2 epithelial cells. In Vitro Cell. Dev. Biol. 43: 147–152; 2007.
Housley R. M.; Morris C. F.; Boyle W.; Ring B.; Biltz R.; Tarpley J. E.; Aukerman S. L.; Devine P. L.; Whitehead R. H.; Pierce G. F. Keratinocyte growth factor induces proliferation of hepatocytes and epithelial cells throughout the rat gastrointestinal tract. J. Clin. Invest. 94: 1764–1777; 1994.
Ido A.; Numata M.; Kodama M.; Tsubouchi H. Mucosal repair and growth factors: recombinant human hepatocyte growth factor as an innovative therapy for inflammatory bowel disease. J. Gastroenterol. 40: 925–931; 2005.
Kenny E. F.; O’Neill L. A. J. Signaling adaptors used by Toll-like receptors: an update. Cytokine 43: 342–349; 2008.
Kane L. P.; Shapiro V. S.; Stokoe D.; Weiss A. Induction of NF–κB by the Akt/PKB kinase. Curr. Biol. 9: 601–604; 1999.
Kitamura S.; Kindo S.; Shinomura Y.; Isozaki K.; Kanavama S.; Higashimoto Y.; Minami T.; Kivohara T.; Yasunaga Y.; Ishikawa H.; Ohtani T.; Ishiguro S.; Matsuzawa Y. Expression of hepatocyte growth factor and c-met in ulcerative colitis. Inflamm. Res. 49: 320–324; 2000.
Laukoetter M.; Nava M.; Nusrat A. Role of the intestinal barrier in inflammatory bowel disease. World J. Gastroenterol. 14: 401–407; 2008.
Ligumsky M.; Simon P. L.; Karmeli F.; Rachmilewitz D. Role of interleukin 1 in inflammatory bowel disease-enhanced production during active disease. Gut 31: 686–689; 1990.
Mehta P. B.; Robson C. N.; Neal D. E.; Leung H. Y. Keratinocyte growth factor activates p38 MAPK to induce stress fibre formation in human prostate DU145 cells. Oncogene 20: 5359–5365; 2001.
Niu H.; Chang Z.; Peng B.; Xia Q.; Lu W.; Huang P.; Tsao M. S.; Chiao P. J. Keratinocyte growth factor/fibroblast growth factor-7-regulated cell migration and invasion through activation of NF–κB transcription factors. J. Biol. Chem. 282: 6001–6011; 2007.
Parhar K.; Eivemark S.; Assi K.; Gomez-Munoz A.; Yee A.; Salh B. Investigation of interleukin 1beta-mediated regulation of NF–kappaB activation in colonic cells reveals divergence between PKB and PDK-transduced events. Mol. Cell. Biochem. 300: 113–127; 2007.
Powis G.; Bonjouklian R.; Berggren M. M.; Gallegos A.; Abraham R.; Ashendel C.; Zalkow L.; Matter W. F.; Dodge J.; Grindey G. Wortmannin, a potent and selective inhibitor of phosphatidylinositol-3-kinase. Cancer Res. 54: 2419–2423; 1994.
Rahimi N.; Tremblay E.; Elliott B. Phosphatidylinositol 3-kinase activity is required for hepatocyte growth factor-induced mitogenic signals in epithelial cells. J. Biol. Chem. 271: 24850–24855; 1996.
Rubin J. S.; Bottaro D. P.; Chedid M.; Miki T.; Ron D.; Cheon G.; Taylor W. G.; Fortney E.; Sakata H.; Finch P. W. Keratinocyte growth factor. Cell Biol. Int. 19: 399–411; 1995.
Sturm A.; Baumgart D. C.; d’Heureuse J. H.; Hotz A.; Wiedenmann B.; Dignass A. U. CXCL8 modulates human intestinal epithelial cells through a CXCR1 dependent pathway. Cytokine 29: 42–48; 2005.
Song G.; Ouyang G.; Bao S. The activation of Akt/PKB signaling pathway and cell survival. J. Cell. Mol. Med. 9: 59–71; 2005.
Tamura M.; Arakaki N.; Tsubouchi H.; Takada H.; Daikuhara Y. Enhancement of human hepatocyte growth factor production by interleukin-1 alpha and -1 beta and tumor necrosis factor-alpha by fibroblasts in culture. J. Biol. Chem. 268: 8140–8145; 1993.
Vitkus S. J.; Hanifin S. A.; McGee D. W. Factors affecting Caco-2 intestinal epithelial cell interleukin-6 secretion. In Vitro Cell. Dev. Biol. 34: 660–664; 1998.
Werner S. Keratinocyte growth factor: a unique player in epithelial repair processes. Cytokine Growth Factor Rev. 9: 153–165; 1998.
Werner S.; Peters K. G.; Longaker M. T.; Fuller-Pace F.; Banda M. J.; Williams L. T. Large induction of keratinocyte growth factor expression in the dermis during wound healing. Proc. Nat. Acad. Sci. U.S.A. 89: 6896–6900; 1992.
Wilson A. J.; Byron K.; Gibson P. R. Interleukin-8 stimulates the migration of human colonic epithelial cells in vitro. Clin. Sci. Lond. 97: 385–390; 1999.
Yang L.; Dan H. C.; Sun M.; Liu Q.; Sun X. M.; Feldman R. I.; Hamilton A. D.; Polokoff M.; Nicosia S. V.; Herlyn M.; Sebti S. M.; Cheng J. Q. Akt/protein kinase B signaling inhibitor-2, a selective small molecule inhibitor of Akt signaling with antitumor activity in cancer cells overexpressing Akt. Cancer Res. 64: 4394–399; 2004.
Zeeh J. M.; Procaccino F.; Hoffmann P.; Aukerman S. L.; McRoberts J. A.; Soltani S.; Pierce G. F.; Lakshmanan J.; Lacey D.; Eysselein V. E. Keratinocyte growth factor ameliorates mucosal injury in an experimental model of colitis in rats. Gastroenterology 110: 1077–1083; 1996.
Zimmerman N. P.; Vongsa R. A.; Wendt M. K.; Dwinell M. B. Chemokines and chemokine receptors in mucosal homeostasis at the intestinal epithelial barrier in inflammatory bowel disease. Inflamm. Bowel Dis. 14: 1000–1011; 2008.
Acknowledgements
The authors wish to gratefully acknowledge Jill Grygas for her assistance with the technical aspects of this paper. This work was supported by US PHS Grant DK54049.
Author information
Authors and Affiliations
Corresponding author
Additional information
Editor: J. Denry Sato
Rights and permissions
About this article
Cite this article
Unger, B.L., McGee, D.W. Hepatocyte growth factor and keratinocyte growth factor enhance IL-1-induced IL-8 secretion through different mechanisms in Caco-2 epithelial cells. In Vitro Cell.Dev.Biol.-Animal 47, 173–181 (2011). https://doi.org/10.1007/s11626-010-9365-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11626-010-9365-4